Skip to content

Clinical trials

Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Country / region: United States Clear all

957 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200128
200214
200322
200433
200536
200627
200732
200828
200927
201035
201124
201237
201322
201427
201538
201640
201739
201832
201945
202045
202136
202236
202334
202427
202544
202638

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed504
Terminated142
Recruiting138
Active, not recruiting89
Withdrawn32
Unknown status26
Not yet recruiting11
Suspended6
Enrolling by invitation4
No longer available3
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)112
Memorial Sloan Kettering Cancer Center64
M.D. Anderson Cancer Center44
Children's Oncology Group29
Dana-Farber Cancer Institute19
Washington University School of Medicine18
Eli Lilly and Company16
Fred Hutchinson Cancer Center16
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins16
Mayo Clinic14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma957
Breast Neoplasms136
Osteosarcoma136
Melanoma131
Ovarian Neoplasms119
Neoplasms108
Neuroblastoma105
Rhabdomyosarcoma101
Sarcoma, Ewing81
Lymphoma80

Trials

Showing 1 to 25 of 957. Each trial links to its page on Pharma Observatory.

857 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.